|
|
||||||||
Journal of Applied Physiology, Vol 67, Issue 6 2397-2400, Copyright © 1989 by American Physiological Society
ARTICLES |
K. Sekizawa, P. D. Graf and J. A. Nadel
Cardiovascular Research Institute, University of California, San Francisco 94143-0130.
We studied the effect of somatostatin on contractile responses to electrical field stimulation (EFS) in isolated ferret tracheal segments. Somatostatin (up to 10(-5) M) did not change resting tension, but it potentiated the contractile response to EFS dose dependently, with a maximum effect at 10(-6) M. Thus, at a concentration of 10(-6) M, somatostatin significantly decreased the mean log of EFS frequency producing 50% of maximum contraction from a control value of 0.52 +/- 0.07 to 0.24 +/- 0.06 (SE) Hz (P less than 0.01). The potentiating effect of somatostatin (10(-6) M) was not inhibited by hexamethonium, indomethacin, BW755C, pyrilamine, methysergide, or D,Pro2,D,Trp7,9-SP, but it was inhibited by atropine or by the somatostatin antagonist cyclo[7-aminoheptanoyl-Phe-D-Trp-Lys-Thr(Bzl)]. In contrast to EFS-induced contraction, contractions produced by acetylcholine (10(-9) to 10(-3) M) were not affected by somatostatin at a concentration of 10(-6) M. These results suggest that somatostatin potentiates contractions produced by EFS via presynaptic cholinergic mechanisms and probably through a specific somatostatin receptor.
This article has been cited by other articles:
![]() |
U. Smedh, J. M. Kaplan, E. Bjorkstrand, and K. Uvnas-Moberg Dual effects of somatostatin analog octreotide on gastric emptying during and after intragastric fill Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1999; 277(5): R1291 - R1296. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |